Silencing of sinusoidal DDR1 reduces murine liver metastasis by colon carcinoma.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 10 2020
27 10 2020
Historique:
received:
27
04
2020
accepted:
07
10
2020
entrez:
28
10
2020
pubmed:
29
10
2020
medline:
11
3
2021
Statut:
epublish
Résumé
Liver metastasis depends on the collagenous microenvironment generated by hepatic sinusoidal cells (SCs). DDR1 is an atypical collagen receptor linked to tumor progression, but whether SCs express DDR1 and its implication in liver metastasis remain unknown. Freshly isolated hepatic stellate cells (HSCs), Kupffer cells (KCs), and liver sinusoidal endothelial cells (LSECs), that conform the SCs, expressed functional DDR1. HSCs expressed the largest amounts. C26 colon carcinoma secretomes increased DDR1 phosphorylation in HSCs and KCs by collagen I. Inhibition of kinase activity by DDR1-IN-1 or mRNA silencing of DDR1 reduced HSCs secretion of MMP2/9 and chemoattractant and proliferative factors for LSECs and C26 cells. DDR1-IN-1 did not modify MMP2/9 in KCs or LSECs secretomes, but decreased the enhancement of C26 migration and proliferation induced by their secretomes. Gene array showed that DDR1 silencing downregulated HSCs genes for collagens, MMPs, interleukins and chemokines. Silencing of DDR1 before tumor inoculation reduced hepatic C26 metastasis in mice. Silenced livers bore less tumor foci than controls. Metastatic foci in DDR1 silenced mice were smaller and contained an altered stroma with fewer SCs, proliferating cells, collagen and MMPs than foci in control mice. In conclusion, hepatic DDR1 promotes C26 liver metastasis and favors the pro-metastatic response of SCs to the tumor.
Identifiants
pubmed: 33110221
doi: 10.1038/s41598-020-75395-w
pii: 10.1038/s41598-020-75395-w
pmc: PMC7591579
doi:
Substances chimiques
Ddr1 protein, mouse
EC 2.7.10.1
Discoidin Domain Receptor 1
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18398Références
Cell Adh Migr. 2018;12(4):363-377
pubmed: 29701112
Nature. 2019 Mar;567(7747):249-252
pubmed: 30842658
Hepatology. 2010 Jun;51(6):2172-82
pubmed: 20513002
ACS Chem Biol. 2013 Oct 18;8(10):2145-50
pubmed: 23899692
BMC Cancer. 2017 Jan 31;17(1):87
pubmed: 28143619
J Clin Invest. 2001 Mar;107(6):727-35
pubmed: 11254672
Jpn J Cancer Res. 2000 Dec;91(12):1285-95
pubmed: 11123428
Nat Cell Biol. 2011 Jan;13(1):49-58
pubmed: 21170030
EMBO Mol Med. 2018 Apr;10(4):
pubmed: 29438985
Hepatology. 1999 Jun;29(6):1760-7
pubmed: 10347119
J Immunol. 2004 Feb 15;172(4):2332-40
pubmed: 14764702
Mol Oncol. 2019 Sep;13(9):1855-1873
pubmed: 31116512
Cancer Microenviron. 2011 Aug;4(2):163-80
pubmed: 21870094
Exp Biol Med (Maywood). 2016 Sep;241(15):1639-52
pubmed: 27390264
Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53
pubmed: 18938156
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Biol Open. 2019 Aug 9;8(8):
pubmed: 31362952
Hepatology. 1997 Sep;26(3):634-42
pubmed: 9303493
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Clin Cancer Res. 2016 Dec 15;22(24):5971-5982
pubmed: 27797969
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232274
Cell Adh Migr. 2018;12(4):348-362
pubmed: 29513135
Am J Pathol. 2011 Mar;178(3):1134-44
pubmed: 21356365
J Leukoc Biol. 1985 Aug;38(2):213-30
pubmed: 2993459
Mol Cell. 1997 Dec;1(1):13-23
pubmed: 9659899
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
Mol Cancer Res. 2018 Oct;16(10):1590-1600
pubmed: 29866925
Hepatology. 2003 Mar;37(3):674-85
pubmed: 12601365
Biochim Biophys Acta Mol Cell Res. 2019 Nov;1866(11):118483
pubmed: 31108116
J Clin Invest. 2001 Nov;108(9):1369-78
pubmed: 11696582
Cell Adh Migr. 2020 Dec;14(1):69-81
pubmed: 32090682
Gut. 2012 Oct;61(10):1465-72
pubmed: 22071959
Free Radic Biol Med. 2007 Feb 1;42(3):343-52
pubmed: 17210447
J Transl Med. 2019 Sep 14;17(1):309
pubmed: 31521169
J Biol Chem. 2019 Dec 20;294(51):19723-19739
pubmed: 31699892
J Biol Chem. 2018 Feb 23;293(8):2841-2849
pubmed: 29298894
J Pharmacol Exp Ther. 2012 Mar;340(3):510-9
pubmed: 22128347
Hepatology. 2011 Aug;54(2):707-13
pubmed: 21520207
J Mol Biol. 2014 Jun 26;426(13):2457-70
pubmed: 24768818
Fibrogenesis Tissue Repair. 2012 Feb 15;5:3
pubmed: 22336030
Innate Immun. 2008 Aug;14(4):255-66
pubmed: 18669611
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1878-1889
pubmed: 29930002
Front Pharmacol. 2016 Mar 14;7:55
pubmed: 27014069
Cancers (Basel). 2018 Nov 28;10(12):
pubmed: 30487436
Sci Rep. 2020 Feb 11;10(1):2309
pubmed: 32047176
Cell. 2016 Jun 30;166(1):47-62
pubmed: 27368100
Circ Res. 2010 Jun 11;106(11):1775-83
pubmed: 20448217
Biochim Biophys Acta. 2013 Oct;1832(10):1765-75
pubmed: 23770341
Int Rev Cell Mol Biol. 2014;310:39-87
pubmed: 24725424
Plast Reconstr Surg. 2000 Dec;106(7):1532-40
pubmed: 11129182
Biochim Biophys Acta Mol Cell Res. 2019 Nov;1866(11):118474
pubmed: 30954571
Sci Rep. 2019 Sep 11;9(1):13111
pubmed: 31511625